6505--Naproxen Tablets

Closed Pre-Solicitation Posted

This opportunity was awarded. See the award notice from , or the latest solicitation from .

Solicitation number
36E79726R0011
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs National Acquisition Center is seeking to procure Naproxen Tablets through an unrestricted competitive procurement under Request for Proposal 36E79726R0011. The solicitation will support supply needs for the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service through the VA's Pharmaceutical Prime Vendor Programs. Offerors must provide the exact product name as it appears on the label and supply a unique NDC/UPC number to qualify for consideration. The VA will award a single contract to the responsible offeror demonstrating the capability to provide an uninterrupted source of supply. The RFP will be issued in commercial item format in accordance with FAR Part 12 on or about February 10, 2026, with a tentative closing date of February 24, 2026 at 2:30 PM Central Time. All solicitation documents will be available electronically at www.beta.sam.gov, and interested parties should direct questions to Michael Olszewski at michael.olszewski@va.gov or 708-786-4966.

This procurement includes no set-aside designations and will be competed among all responsible sources. The contract structure consists of one base year plus four pre-priced one-year option periods, providing up to five years of potential supply. The total estimated annual requirement is approximately 153,363 bottles across six line items, encompassing Naproxen Tablets in 250MG, 375MG, and 500MG strengths in both 100-bottle and 500-bottle package configurations. Annual quantities range from 1,476 bottles for 375MG tablets in 100-bottle packages to 115,664 bottles for 500MG tablets in 500-bottle packages. The NAICS classification is 325412 (Pharmaceutical Preparation Manufacturing), and the procurement is classified under PSC 6505 (Drugs and Biologicals).

Notice text

Presolicitation Notice

Page 1 of

Presolicitation Notice

Page 1 of 3

Presolicitation Notice

*=Required Field

Presolicitation Notice

Page 4 of 4

DESCRIPTION

Presolicitation Notice

Presolicitation Notice

Page 3 of 3

Page 1 of 2

Page 1 of 2

Presolicitation Notice

*=Required Field

Presolicitation Notice

Page 1 of 3

Page 1 of

Page 1 of

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0011 for an unrestrictive procurement for Naproxen Tablets for the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC/UPC number. The standard package unit of use is bottles. Solicitation #36E79726R0011 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about February 10, 2026, with a tentative closing date of February 24, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: www.beta.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Michael Olszewski. Questions can be e-mailed to: Michael.Olszewski@va.gov.

The estimated annual requirements are as follows:

ITEM

DESCRIPTION

PACKAGE SIZE (Tablets per Bottle)

TOTAL

ESTIMATED

ANNUAL

USAGE

(Bottles)

1

NAPROXEN 250MG TAB

100

4,420

2

NAPROXEN 250MG TAB

500

14,256

3

NAPROXEN 375MG TAB

100

1,476

4

NAPROXEN 375MG TAB

500

8,553

5

NAPROXEN 500MG TAB

100

8,994

6

NAPROXEN 500MG TAB

500

115,664

Files

File Type Posted
36E79726R0011_1.docx DOCX document

Notice history

Notice Type Posted
6505--Naproxen Tablets 8-1-2026 - 7-31-2027 Award Award Notice
6505--Naproxen Tablets Latest solicitation Solicitation
This notice Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Sodium Bicarbonate Injection Vial Restricted to Made in America NAICS 325412 National Acquisition Center No set-aside
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity